
Cellectis
ALCLS | XPAR
Overview
Corporate Details
- ISIN(s):
- FR0010425595 (+2 more)
- LEI:
- 5493000KKX5VQ37Q2W83
- Country:
- France
- Address:
- 8 RUE DE LA CROIX JARRY, 75013 PARIS
- Website:
- https://cellectis.com/en
- Sector:
- Health Care
- Industry:
- Biotechnology
Description
Cellectis is developing the first of its kind allogeneic approach for CAR-T immunotherapies in oncology, pioneering the concept of off-the-shelf and ready-to-use gene-edited CAR T-cells to treat cancer patients. As a clinical-stage biopharmaceutical company with over 21 years of expertise in gene editing, Cellectis is developing life-changing product candidates utilizing TALEN®, its proprietary gene editing technology, and PulseAgile, its pioneering electroporation system to harness the power of the immune system in order to target and eradicate cancer cells. As part of its commitment to a cure, Cellectis remains dedicated to its goal of providing life-saving UCART product candidates to address unmet needs for multiple cancers including acute myeloid leukemia (AML), B-cell acute lymphoblastic leukemia (B-ALL), multiple myeloma (MM), Hodgkin lymphoma (HL) and non-Hodgkin lymphoma (NHL).
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Filings
Date | Filing | Language | Size | Actions |
---|---|---|---|---|
2025-05-21 22:30 |
General Meeting Notice
L’Assemblée Générale Mixte de Cellectis se tiendra le 26 juin 2025
|
French | 44.7 KB | |
2025-05-21 22:30 |
General Meeting Notice
Cellectis’ Annual Shareholders General Meeting to be Held on June 26, 2025
|
English | 84.0 KB | |
2025-05-12 22:30 |
Earnings Release
Cellectis publie ses résultats financiers du premier trimestre 2025
|
French | 232.9 KB | |
2025-05-12 22:30 |
Earnings Release
Cellectis Reports Financial Results for the First Quarter 2025
|
English | 216.6 KB | |
2025-05-07 22:30 |
Declaration of Voting Results & Voting Rights Announcements
Information mensuelle relative au nombre total des droits de vote et d’actions …
|
French | 83.3 KB | |
2025-05-07 22:30 |
Declaration of Voting Results & Voting Rights Announcements
Monthly information on share capital and company voting rights
|
English | 84.8 KB | |
2025-05-06 22:30 |
Earnings Release
Cellectis publiera ses résultats financiers du premier trimestre le 12 mai 2025
|
French | 67.7 KB | |
2025-05-06 22:30 |
Earnings Release
Cellectis to Report First Quarter Financial Results on May 12, 2025
|
English | 77.3 KB | |
2025-04-28 22:39 |
Regulatory News Service
Cellectis présente une approche non virale d’édition du génome et des innovatio…
|
French | 190.3 KB | |
2025-04-28 22:30 |
Regulatory News Service
Cellectis Presents Non-Viral Gene Editing and Base Editing Innovation at the AS…
|
English | 75.1 KB | |
2025-04-07 22:30 |
Declaration of Voting Results & Voting Rights Announcements
Information mensuelle relative au nombre total des droits de vote et d’actions …
|
French | 122.2 KB | |
2025-04-07 22:30 |
Declaration of Voting Results & Voting Rights Announcements
Monthly information on share capital and company voting rights
|
English | 91.5 KB | |
2025-03-13 23:46 |
Annual Report
Cellectis publie ses résultats financiers du quatrième trimestre 2024 et de l’e…
|
French | 250.5 KB | |
2025-03-13 23:07 |
Annual Report
Cellectis Reports Financial Results for the Fourth Quarter and Full Year 2024 a…
|
English | 244.6 KB | |
2025-03-07 22:30 |
Earnings Release
Cellectis to Report Fourth Quarter and Full Year 2024 Financial Results on Marc…
|
English | 83.5 KB |
Insider Transactions
Date | Insider Name | Position | Type | Shares | Value |
---|---|---|---|---|---|
No insider transactions recorded for this company. |
Peer Companies
Company | Country | Ticker | View | |
---|---|---|---|---|
![]() |
1NKEMIA | Spain | IKM | |
![]() |
2cureX AB | Sweden | 2CUREX | |
![]() |
4SC AG | Germany | VSC | |
![]() |
Abera Bioscience AB | Sweden | ABERA | |
![]() |
ABIONYX Pharma | France | ABNX | |
|
Abliva | Sweden | ABLI | |
![]() |
AB Science | France | AB | |
![]() |
Acticor Biotech | France | ALACT | |
![]() |
Active Biotech | Sweden | ACTI | |
![]() |
AcuCort AB | Sweden | ACUC |